Fluid management is a complex subject in healthcare, particularly when pertaining to critically ill patients. Following a literature search on international recommendations regarding fluid administration for shocked patients, an audit was undertaken at Rotorua Public Hospital, New Zealand, to assess how the local fluid resuscitation strategy could be improved. The first part of the audit looked at the fluid resuscitation approach used to treat shocked patients admitted to the ICU of Rotorua Hospital in 2014 and changes required to achieve best practice recommendations. The second part tested the success and impact of the subsequently implemented, more measured approach to fluid resuscitation in 2016. Data was extracted from patient files, fluid charts and electronic records to assess fluid administration and de-escalation measures. The collated information was analysed and compared to recommendations found in the literature. The complete audit cycle revealed not only a significant improvement in adherence to best practice guidelines, but also an association with better patient outcomes.
Fluid resuscitation in critically ill patients has a significant impact on morbidity 1,2 and mortality 1, 3 in the intensive care unit (ICU). Literature provides clear evidence that underresuscitation and development of clinical shock (defined as circulatory failure, evidenced by inadequate tissue perfusion resulting in organ dysfunction 4 ) is associated with worse prognosis, but can be improved with early resuscitation with intravenous fluids (IVF) 4, 5 . Conversely, research has linked fluid overload, a potential consequence of IVF, to tissue congestion with worsening organ function which is similarly associated with poorer outcomes 2, 6 . The speed, severity and persistence of fluid accumulation 7, 8 has a positive correlation with ICU mortality. The challenge remains as regards the best measures to determine the right dose at the right time.
Consensus international guidelines on the management of shock (independent of aetiology) state that patients should receive early adequate fluid resuscitation followed by a more restrictive strategy 4, 9 . Based on these, three standards were identified: 1. After initial resuscitation, a positive cumulative balance should be avoided 10 . 2. After 72 hours of resuscitation, a negative daily cumulative balance should be achieved 6 . 3. Active management with diuretics for patients with maintained urine output, or renal replacement therapy (RRT) for oligo/anuric patients, should be initiated after the acute resuscitation.
The aim of this audit was to compare the fluid resuscitation practice in 2014 at Rotorua Intensive Care Unit against the aforementioned standards to data in 2016 after the implementation of best practice recommendations.
We divided the fluid resuscitation episodes into three phases, similar to how it is described in the literature 6, 11, 12 : the initial resuscitation or 'phase 1' (first 36 hours from shock onset); the optimisation/maintenance phase or 'phase 2' (36 to 72 hours); and the de-escalation phase or 'phase 3' (>72 hours). The resultant impact on morbidity and mortality outcomes were also assessed.
Method
Our audit was approved as a quality improvement project by Lakes District Health Board Audit Department, project ID number 2016.9. It was a complete audit cycle, where baseline data was collected, recommendations derived and implemented with the re-audit completed to review and consolidate the instigated changes.
The initial audit involved a retrospective review of relevant documentation of 105 consecutive patients admitted to Rotorua ICU between January to December 2014 (one-year period), who required vasopressor and/or inotropic support (suggesting shock). Seventy patients had to be excluded as they were discharged prior to 'phase 3' of resuscitation, leaving 35 patients eligible for analysis ( Figure 1 , on next page).
The re-audit consisted of a retrospective review of consecutive ICU admissions requiring vasopressor and/ or inotropic support from January to June 2016. Of these 38 patients, 20 were included in the audit due to 18 being discharged early or IVF being contraindicated ( Figure 1 ).
Our data collection started from the time the treating clinician first documented the patient to be 'shocked' (i.e. circulatory failure driving end-organ dysfunction), and included each resuscitation phase outlined above.
Patients were eligible for inclusion if they were shocked, transferred to the ICU unit within phase 1 and received IVF resuscitation in ICU. Patients were excluded if IVF was contraindicated/cautioned (e.g. congestive heart failure), if they were not given full resuscitation (e.g. palliative intent), if they died or were discharged from ICU before phase 3 resuscitation, or if there was insufficient documentation to complete the data collection.
Data was collected from ICU fluid balance charts, medication charts, laboratory results and clinical notes (both paper and electronic versions). Baseline demographic information, fluid accumulation over various points of the resuscitation process, de-escalation means and morbidity/ mortality outcomes were recorded on a Microsoft Excel (2007) spreadsheet (Microsoft, Redmond, WA, USA). Clinical outcomes were only recorded if specifically documented by the treating physician.
Between 2014 and the re-audit in 2016, a number of changes took place, both in Rotorua and internationally, that affected IVF resuscitation practice. International studies highlighted the importance of, initially a liberal, then a restrictive fluid approach in the resuscitation of shocked patients to improve outcomes. The presentation of our first audit cycle allowed us to make recommendations and assist with instigating changes within the department which were in discussion at the time. Rotorua ICU updated the bedside observation chart to accurately identify hourly, 24 hourly and total length-of-stay cumulative balance. Fluid prescribing was regulated to occur only on the national drug chart whereas previously, it could occur either on the ICU chart or drug chart or both. These changes allowed precise tracking of IVF accumulation. Through increasing awareness (which was easily done in a small hospital with only 16 ICU consultants/ anaesthetists) we were able to influence a change in practice which moved away from 'routine' maintenance IVF, where fluids were continued when bags finished without careful medical re-evaluation, to a more restrictive approach.
Simultaneously, a local series of acute respiratory distress patients in 2014-all requiring extracorporeal membrane oxygenation support-and yearly outcome audits of 'enhanced recovery after surgery' bowel surgical patients identified our own shortcomings in fluid management, necessitating a paradigm shift to 'less fluid is more'. 
Results
One hundred and thirty-nine (139) patients were identified as being admitted to Rotorua ICU in 2014 and receiving vasopressor/inotropic support. Of these, 105 fulfilled the inclusion criteria with 70 then excluded based on the exclusion criteria. Thirty-eight patients were identified in the repeat six-month audit in 2016, of which 18 were excluded, leaving a sample set of 20. Relevant patient demographics are in Table 1 .
Our first standard recommended an avoidance of positive cumulative balance following the first resuscitation phase. In 2014, only 14% (n=5) had a negative 24-hour accumulation in phase 2 resuscitation, with the remainder having a positive cumulative balance; 11% (n=4) reached a >3 litre positive 24-hour fluid balance ( Figure 2 ).
In 2016, 50% (n=10) had a negative 24-hour accumulation in phase 2, the remainder being positive; only 5% (n=1) had >3 litre positive 24-hour fluid balance (Figure 2 ).
Our second standard recommended negative daily cumulative balance after 72 hours' resuscitation. In 2014, of those who remained in ICU for phase 3, 28% (n=7) attained a negative cumulative fluid balance, with those remaining having a positive cumulative balance; 32% (n=8) received a daily cumulative balance of >1 litre (Figure 3) .
In 2016, of those who remained in ICU for phase 3, 27% (n=3) attained a negative cumulative fluid balance, with those remaining having a positive cumulative balance; however all of these had only a zero to one litre positive daily cumulative balance, with no patients reaching more than one litre (Figure 3) .
Our third standard recommended that active management with diuretics, or RRT, should be carried out after the acute resuscitation. We recorded data on both diuretic and RRT use, as well as fluid restriction or cessation of IVF.
In 2014, 77% (n=27) had some sort of de-escalation method used (note the methods are not mutually exclusive): of those patients who did, 30% (n=8) used diuretics, 11% (n=3) had RRT use, 11% (n=3) had fluid restriction and 85% (n=23) had IVF cessation (Figure 4 , on next page).
In 2016, 100% (n=20) had received one or more types of de-escalation: of those patients 35% (n=7) used diuretics; 10% (n=2) had RRT use; 10% (n=2) had fluid restriction; and 100% (n=20) had IVF cessation (Figure 4 ).
Another surrogate marker of IVF management is the peak positive cumulative fluid balance attained during ICU admission. In 2014, 26% (n=9) of patients achieved a peak cumulative fluid balance of 12 litres or more, 6% (n=2) were between 16 and 20 litres, and 6% (n=2) were greater than 20 litres ( Figure 5 ). In 2016, only 5% (n=1) of the sample had a peak cumulative fluid balance of 12 litres or more, with no patients represented as having a peak cumulative fluid balance greater than 16 litres ( Figure 5) .
To investigate the clinical significance of change in fluid management between 2014 and 2016, we collected data on clinical outcomes. These included rates of acute renal impairment/failure (RIFLE criteria -risk, injury, failure, loss of function, end-stage renal disease); 'other medical complications' (ventilator-associated and hospitalacquired pneumonias, new-onset atrial fibrillation or other arrhythmias, myocardial infarction, pulmonary oedema, and acute respiratory distress syndrome); 'surgical complications' (ileus, prolonged ileus >5 days, anastomotic leak, wound infection, prolonged wound ooze and wound dehiscence); and mortality.
Forty-six percent (n=16) of the 2014 audited patients experienced some degree of acute kidney injury and/or acute renal failure, compared to 40% (n=8) of the 2016 sample. Medical complications reduced, with 80% of patients (n=16) having no complications in 2016 compared to 57.14% (n=20) in 2014. The number of complications also reduced ( Figure 6 ). With regard to surgical complications, 28.57% (n=10) of the 2014 sample experienced at least one complication, compared to 15% (n=3) of the 2016 sample (Figure 7) . Mortality rates also improved with an overall mortality by three months of 31% (n=11) in 2014 compared to 10% overall mortality by three months in 2016 ( Figure 8 ).
Discussion
Every effort was taken to reduce bias to ensure validity of results, but some limitations were inevitable. Working in a small hospital, our data was limited by a smaller population leading to a small sample size when only including those staying in the ICU for >72 hours.
Having two auditors compile information for this audit may have been a potential limitation but this was overcome through consistent collaboration and cross-referencing throughout the audit process.
Our data collection was based on a retrospective review of ICU charts and patients' notes, and therefore relied on the quality and completeness of clinical documentation. We think interpretation error was small since the majority of our data dealt with discrete values such as absolute numbers for fluid balances.
We did not account for insensible losses. This may have falsely increased cumulative balances for some patients; this also applied to the re-audit and hence is unlikely to have resulted in significant deviation between the two datasets.
Subgroup analysis of different diagnoses of shock was not done, meaning we did not examine how different shock categories fared in relation to the 2014 versus the 2016 IVF resuscitation approach.
We did not take into account patients' severity of illness scores. We can assume that patients who have a more severe illness may often require a more prolonged resuscitation, and most likely need more IVF than less sick patients. This leaves the possibility that patients in 2014 may have been more unwell than in 2016.
After careful consideration of the limitations, we do consider our data clinically useful and relevant to our practice.
Conclusion
With the variable nature of fluid management, it is difficult to create highly directive guidelines, which can be applied as a 'blanket rule'. It is imperative for clinicians to review IVF resuscitation as a risk versus benefit ratio. To do this it must be easy for the clinician to track fluid administration. We would recommend that ICUs ensure they have a similar system to what Rotorua ICU have adopted: ensuring fluids are strictly charted on one consistent chart, and that fluid administration charts show easy-to-read fluid values and cumulative totals.
Fluids should only be given if the patient is likely to be fluid responsive. There has been a strong focus on monitoring haemodynamic variables in shocked patients to guide fluid management more accurately 12, 13 . Assessment of fluid responsiveness can vary from simple manoeuvres to expertguided interpretation of invasive monitoring. The passive leg raise manoeuvre with cardiac output monitoring has been shown to be simple and effective 14 . Echocardiography has become an increasingly common bedside tool in the ICU setting and can be used as an effective means to monitor fluid responsiveness non-invasively by quantifying changes in stroke volume in response to interventions 15 . There has been an increasing use of point-of-care echocardiography (ECHO) in Rotorua ICU patients between 2014 and 2016, which may have supported the paradigm shift from liberal to tapered fluid resuscitation. The majority of senior medical staff in the ICU department have completed an advanced ECHO course and now frequently use the acquired ultrasound skills for clinical decision-making at the bedside. ECHO parameters typically used to assess fluid responsiveness are inferior vena cava compressibility and ventricular filling dynamics.
Lastly, we believe higher quality studies are needed in the area of fluid administration to further improve our management strategy and patient outcomes.
In conclusion, our audit cycle revealed a significant care improvement for clinically shocked ICU patients at Rotorua Hospital. There was a measurable improvement in patient outcomes in 2016 through the adoption of international best practice standards on IVF resuscitation and improved care processes (revised ICU observation chart, fluid prescription, teaching and education). We believe the key contributors leading to improved clinical outcomes resulted from cessation of routine IVF therapy and increased use of de-escalation in the form of diuretics. Encouraged by these positive outcomes, the ICU team will continue to strive to adopt evidence-based quality care practices in an everevolving medical specialty.
